SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Ekso Bionics Holdings, Inc. – ‘10-Q’ for 9/30/19

On:  Wednesday, 10/30/19, at 4:28pm ET   ·   For:  9/30/19   ·   Accession #:  1549084-19-7   ·   File #:  1-37854

Previous ‘10-Q’:  ‘10-Q’ on 8/1/19 for 6/30/19   ·   Next:  ‘10-Q’ on 4/30/20 for 3/31/20   ·   Latest:  ‘10-Q’ on 4/29/24 for 3/31/24

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

10/30/19  Ekso Bionics Holdings, Inc.       10-Q        9/30/19   84:7.7M

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    622K 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     30K 
 3: EX-31.2     Certification -- §302 - SOA'02                      HTML     30K 
 4: EX-32.1     Certification -- §906 - SOA'02                      HTML     25K 
 5: EX-32.2     Certification -- §906 - SOA'02                      HTML     25K 
61: R1          Document And Entity Information                     HTML     50K 
19: R2          Condensed Consolidated Balance Sheets               HTML    115K 
43: R3          Condensed Consolidated Balance Sheets               HTML     46K 
                (Parenthetical)                                                  
75: R4          Condensed Consolidated Statements of Operations     HTML     94K 
                and Comprehensive Income (Loss)                                  
62: R5          Consolidated Statements of Stockholders' Equity     HTML    102K 
20: R6          Condensed Consolidated Statements of Cash Flows     HTML    123K 
44: R7          Organization                                        HTML     40K 
73: R8          Basis of Presentation and Summary of Significant    HTML     72K 
                Accounting Policies and Estimates                                
65: R9          Accumulated Other Comprehensive Income (Loss)       HTML     30K 
26: R10         Fair Value Measurements                             HTML     73K 
32: R11         Inventories, net                                    HTML     33K 
77: R12         Revenue Recognition                                 HTML    124K 
48: R13         Investment in Unconsolidated Affiliate              HTML     38K 
25: R14         Accrued Liabilities                                 HTML     54K 
31: R15         Long-Term Debt                                      HTML     64K 
76: R16         Lease Obligations                                   HTML     48K 
47: R17         Capitalization and Equity Structure                 HTML     97K 
24: R18         Stock-based Compensation                            HTML     97K 
33: R19         Income Taxes                                        HTML     26K 
72: R20         Commitments and Contingencies                       HTML     32K 
64: R21         Net Income (Loss) Per Share                         HTML     69K 
18: R22         Segment Disclosures                                 HTML     98K 
46: R23         Related Party Transactions                          HTML     28K 
71: R24         Subsequent Events                                   HTML     28K 
63: R25         Basis of Presentation and Summary of Significant    HTML    105K 
                Accounting Policies and Estimates (Policies)                     
17: R26         Accumulated Other Comprehensive Income (Loss)       HTML     29K 
                (Tables)                                                         
45: R27         Fair Value Measurements (Tables)                    HTML     71K 
74: R28         Inventories, net (Tables)                           HTML     35K 
60: R29         Revenue Recognition (Tables)                        HTML    115K 
49: R30         Accrued Liabilities (Tables)                        HTML     55K 
80: R31         Long-Term Debt (Tables)                             HTML     57K 
29: R32         Lease Obligations (Tables)                          HTML     40K 
22: R33         Capitalization and Equity Structure (Tables)        HTML     77K 
50: R34         Stock-based Compensation (Tables)                   HTML     99K 
81: R35         Net Income (Loss) Per Share (Tables)                HTML     72K 
30: R36         Segment Disclosures (Tables)                        HTML    100K 
23: R37         Organization (Details)                              HTML     56K 
51: R38         Basis of Presentation and Summary of Significant    HTML     55K 
                Accounting Policies and Estimates (Details)                      
78: R39         Accumulated Other Comprehensive Income (Loss)       HTML     35K 
                (Details)                                                        
55: R40         Fair Value Measurements - Fair Value Hierarchies    HTML     38K 
                (Details)                                                        
67: R41         Fair Value Measurements - Change in Level 3         HTML     43K 
                (Details)                                                        
40: R42         Inventories, net (Details)                          HTML     33K 
15: R43         Revenue Recognition - Deferred Revenue (Details)    HTML     41K 
56: R44         Revenue Recognition - Deferred Revenue Activity     HTML     30K 
                (Details)                                                        
68: R45         Revenue Recognition - Additional Information        HTML     41K 
                (Details)                                                        
41: R46         Revenue Recognition - Performance Obligations       HTML     37K 
                (Details)                                                        
16: R47         Revenue Recognition - Disaggregation of Revenue     HTML     61K 
                (Details)                                                        
57: R48         Investment in Unconsolidated Affiliate - Narrative  HTML     63K 
                (Details)                                                        
66: R49         Investment in Unconsolidated Affiliate -            HTML     37K 
                Additional Information (Details)                                 
83: R50         Accrued Liabilities - Schedule of Accrued           HTML     41K 
                Liabilities (Details)                                            
54: R51         Accrued Liabilities - Product Maintenance and       HTML     30K 
                Warranty (Details)                                               
28: R52         Long-Term Debt - Additional Information (Details)   HTML     57K 
36: R53         Long-Term Debt - Debt Repayment (Details)           HTML     47K 
82: R54         Long-Term Debt - Interest Debt Expense (Details)    HTML     36K 
53: R55         Lease Obligations - Additional Information          HTML     36K 
                (Details)                                                        
27: R56         Lease Obligations - Future Minimum Payments         HTML     48K 
                (Details)                                                        
35: R57         Capitalization and Equity Structure - Additional    HTML    113K 
                Information (Details)                                            
84: R58         Capitalization and Equity Structure - Warrants      HTML     68K 
                (Details)                                                        
52: R59         Capitalization and Equity Structure - Valuation     HTML     50K 
                Assumptions (Details)                                            
14: R60         Stock-based Compensation - Additional Information   HTML     52K 
                (Details)                                                        
38: R61         Stock-based Compensation - Stock Option Activity    HTML     80K 
                (Details)                                                        
70: R62         Stock-based Compensation - Valuation Assumptions    HTML     45K 
                (Details)                                                        
59: R63         Stock-based Compensation - RSU Activity (Details)   HTML     44K 
13: R64         Stock-based Compensation - Compensation Expense     HTML     35K 
                (Details)                                                        
37: R65         Commitments and Contingencies (Details)             HTML     39K 
69: R66         Net Income (Loss) Per Share - Earnings Per Share    HTML     50K 
                (Details)                                                        
58: R67         Net Income (Loss) Per Share - Antidilutive Shares   HTML     35K 
                (Details)                                                        
12: R68         Segment Disclosures - Operating Segments (Details)  HTML     46K 
39: R69         Segment Disclosures - Geographical Segments         HTML     31K 
                (Details)                                                        
34: R70         Related Party Transactions (Details)                HTML     30K 
79: XML         IDEA XML File -- Filing Summary                      XML    151K 
42: EXCEL       IDEA Workbook of Financial Reports                  XLSX     94K 
 6: EX-101.INS  XBRL Instance -- ekso-20190930                       XML   2.42M 
 8: EX-101.CAL  XBRL Calculations -- ekso-20190930_cal               XML    213K 
 9: EX-101.DEF  XBRL Definitions -- ekso-20190930_def                XML    615K 
10: EX-101.LAB  XBRL Labels -- ekso-20190930_lab                     XML   1.61M 
11: EX-101.PRE  XBRL Presentations -- ekso-20190930_pre              XML    970K 
 7: EX-101.SCH  XBRL Schema -- ekso-20190930                         XSD    170K 
21: ZIP         XBRL Zipped Folder -- 0001549084-19-000007-xbrl      Zip    230K 




        
Filing Submission 0001549084-19-000007 – SGML Text

Original SGML Text submitted by:  Ekso Bionics Holdings, Inc.

To view the SGML, please refresh
Refresh emoji
this page.


Top

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., May 14, 10:24:58.1am ET